Deepika Jalota - May 12, 2023 Form 4 Insider Report for PMV Pharmaceuticals, Inc. (PMVP)

Role
Chief Development Officer
Signature
/s/ Winston Kung, by power of attorney
Stock symbol
PMVP
Transactions as of
May 12, 2023
Transactions value $
$0
Form type
4
Date filed
5/15/2023, 06:18 PM
Previous filing
Sep 13, 2022
Next filing
Sep 18, 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PMVP Employee Stock Option (right to buy) Award $0 +125K $0.00 125K May 12, 2023 Common Stock 125K $5.70 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares subject to the option vest in 48 equal monthly installments beginning on June 12, 2023.